Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Oxytocin receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | orexin receptor type 2 | Oxytocin receptor | 388 aa | 332 aa | 23.2 % |
Schistosoma japonicum | ko:K04135 adrenergic receptor, alpha 1a, putative | Oxytocin receptor | 388 aa | 349 aa | 22.9 % |
Echinococcus granulosus | allatostatin A receptor | Oxytocin receptor | 388 aa | 313 aa | 23.6 % |
Echinococcus granulosus | orexin receptor type 2 | Oxytocin receptor | 388 aa | 338 aa | 24.3 % |
Echinococcus multilocularis | allatostatin A receptor | Oxytocin receptor | 388 aa | 311 aa | 21.9 % |
Echinococcus granulosus | neuropeptide receptor | Oxytocin receptor | 388 aa | 324 aa | 21.9 % |
Onchocerca volvulus | Oxytocin receptor | 388 aa | 327 aa | 23.9 % | |
Schistosoma japonicum | ko:K04134 cholinergic receptor, invertebrate, putative | Oxytocin receptor | 388 aa | 323 aa | 21.7 % |
Onchocerca volvulus | Mitochondrial inner membrane protein homolog | Oxytocin receptor | 388 aa | 346 aa | 24.0 % |
Echinococcus multilocularis | neuropeptide receptor | Oxytocin receptor | 388 aa | 324 aa | 21.6 % |
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Oxytocin receptor | 388 aa | 327 aa | 19.3 % |
Onchocerca volvulus | Phospholipase d-related homolog | Oxytocin receptor | 388 aa | 330 aa | 20.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.0084 | 0.0308 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.0084 | 0.1849 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.0721 | 0.0721 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.0084 | 0.1849 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0126 | 0.0454 | 0.1665 |
Schistosoma mansoni | hypothetical protein | 0.0179 | 0.0721 | 0.0721 |
Wolbachia endosymbiont of Brugia malayi | replicative DNA helicase | 0.2025 | 1 | 0.5 |
Echinococcus granulosus | geminin | 0.0179 | 0.0721 | 0.5 |
Treponema pallidum | replicative DNA helicase (dnaB) | 0.2025 | 1 | 0.5 |
Schistosoma mansoni | Replicative DNA helicase | 0.2025 | 1 | 1 |
Mycobacterium ulcerans | replicative DNA helicase DnaB | 0.2025 | 1 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0126 | 0.0454 | 0.1665 |
Mycobacterium tuberculosis | Probable replicative DNA helicase DnaB | 0.2025 | 1 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0126 | 0.0454 | 1 |
Echinococcus multilocularis | geminin | 0.0179 | 0.0721 | 0.5 |
Mycobacterium leprae | PROBABLE REPLICATIVE DNA HELICASE DNAB replicative DNA helicase | 0.2025 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0084 | 0.0308 |
Loa Loa (eye worm) | twinkle helicase | 0.0579 | 0.2728 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0 IU/mg | Antivasopressor activity against V1a receptor in Wistar rat | ChEMBL. | 16539389 |
Activity (functional) | = 0 IU/mg | Antivasopressor activity against V1a receptor in Wistar rat | ChEMBL. | 16539389 |
Activity (functional) | < 0.04 IU/mg | Antidiuretic activity against V2 receptor in Wistar rat at antidiuresis half life of 60 min | ChEMBL. | 16539389 |
Kd (functional) | = 6.1 | Uterotonic activity against OT receptor in Wistar rat in absence of magnesium | ChEMBL. | 16539389 |
pA2 (functional) | = 6.1 | Uterotonic activity against OT receptor in Wistar rat in absence of magnesium | ChEMBL. | 16539389 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.